Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76fb5796d-r6qrq Total loading time: 0 Render date: 2024-04-29T01:23:01.251Z Has data issue: false hasContentIssue false

Chapter 2 - Acute dystonia

Published online by Cambridge University Press:  05 July 2015

By
Anne Marthe Meppelink  and
Mark J. Edwards
Edited by
Joseph H. Friedman
Joseph H. Friedman
Affiliation:
Department of Neurology, Brown University
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Medication-Induced Movement Disorders , pp. 20 - 30
Publisher: Cambridge University Press
Print publication year: 2015

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Akindele, M.O. and Odejide, A.O., 1976. Amodiaquine-induced involuntary movements. BMJ (Clinical Research Ed.), 2(6029), pp. 214–215.CrossRefGoogle ScholarPubMed
Albanese, A. and Lalli, S., 2012. Update on dystonia. Current Opinion in Neurology, 25(4), pp. 483–490.CrossRefGoogle ScholarPubMed
Alevizos, B., Christodoulou, G. and Papageorgiou, C., 2003. Acute dystonia caused by low dosage of olanzapine. Journal of Neuropsychiatry Clinical Neuroscience, pp. 1–7.CrossRefGoogle Scholar
Arnone, D., Hansen, L. and Kerr, J.S., 2002. Acute dystonic reaction in an elderly patient with mood disorder after titration of paroxetine: possible mechanisms and implications for clinical care. Journal of Psychopharmacology, 16(4), pp. 395–397.CrossRefGoogle Scholar
Arvanitis, L.A. and Miller, B.G., 1997. Multiple fixed doses of “Seroquel” (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group. Biological Psychiatry, 42(4), pp. 233–246.CrossRefGoogle ScholarPubMed
Ayd, F.J., 1961. A survey of drug-induced extrapyramidal reactions. JAMA: The Journal of the American Medical Association, 175, pp. 1054–1060.CrossRefGoogle ScholarPubMed
Bateman, D.N. et al., 1989. Extrapyramidal reactions to metoclopramide and prochlorperazine. The Quarterly Journal of Medicine, 71(264), pp. 307–311.Google ScholarPubMed
Benarroch, E.E., 2012. Effects of acetylcholine in the striatum. Recent insights and therapeutic implications. Neurology, 79(3), pp. 274–281.CrossRefGoogle ScholarPubMed
Bonuccelli, U. et al., 1991. Domperidone-induced acute dystonia and polycystic ovary syndrome. Movement Disorders, 6(1), pp. 79–81.CrossRefGoogle ScholarPubMed
Boyce, S. et al., 1990. Differential effects of D1 and D2 agonists in MPTP-treated primates: functional implications for Parkinson’s disease. Neurology, 40(6), pp. 927–933.CrossRefGoogle ScholarPubMed
Burke, R.E. et al., 1985. Tetrabenazine induces acute dystonic reactions. Annals of Neurology, 17(2), pp. 200–202.CrossRefGoogle ScholarPubMed
Burkhard, P.R., 2014. Acute and subacute drug-induced movement disorders. Parkinsonism and Related Disorders, 20 Suppl 1, pp. S 108–12.CrossRefGoogle ScholarPubMed
Castrioto, A. et al., 2008. Acute dystonia induced by the combination of midodrine and perphenazine. Journal of Neurology, 255(5), pp. 767–768.CrossRefGoogle ScholarPubMed
Chakravarty, A., 2005. Neuroleptic-induced acute laryngeal dystonia causing stridor: A lesson to remember. Movement Disorders, 20(8), pp. 1082–1082.CrossRefGoogle ScholarPubMed
Chan, H. et al., 2010. A randomised controlled study of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced acute dystonia or parkinsonism. Journal of Psychopharmacology, 24(1), pp. 91–98.CrossRefGoogle ScholarPubMed
Chen, M.-H. and Liou, Y.-J., 2013. Aripiprazole-associated acute dystonia, akathisia and Parkinsonism in a patient with bipolar I disorder. Journal of Psychopharmacology, pp. 1–2.CrossRefGoogle Scholar
Christodoulou, G., 2005. Antipsychotic drug-induced acute laryngeal dystonia: two case reports and a mini review. Journal of Psychopharmacology, 19(3), pp. 307–311.CrossRefGoogle Scholar
Dew, R.E. and Hughes, D., 2004. Acute dystonic reaction with moderate-dose ziprasidone. Journal of Clinical Psychopharmacotherapy, 24(5), pp. 563–564.CrossRefGoogle ScholarPubMed
Dhikav, V. and Anand, K.S., 2013. Acute dystonic reaction with rivastigmine. International Psychogeriatrics, 25(8), pp. 1385–1386.CrossRefGoogle ScholarPubMed
Donaldson, I. et al., 2011. Marsden’s Book of Movement Disorders, Oxford University Press.Google Scholar
Dressler, D. and Benecke, R., 2005. Diagnosis and management of acute movement disorders. Journal of Neurology, 252(11), pp. 1299–1306.CrossRefGoogle ScholarPubMed
Dubow, J.S. et al., 2008. Acute dystonic reaction associated with foscarnet administration. American Journal of Therapeutics, 15(2), pp. 184–186.CrossRefGoogle ScholarPubMed
Duggal, H.S., 2008. Acute Pisa syndrome and pharnygolaryngeal dystonia due to ziprasidone. The Journal of Neuropsychiatry and Clinical Neurosciences, 20(1), pp. 108–109.CrossRefGoogle ScholarPubMed
Finder, E., Lin, K.M. and Ananth, J., 1982. Dystonic reaction to amitriptyline. The American Journal of Psychiatry, 139(9), p. 1220.Google ScholarPubMed
Garver, D.L. et al., 1976. Pharmacokinetics of red blood cell phenothiazine and clinical effects. Acute dystonic reactions. Archives of General Psychiatry, 33(7), pp. 862–866.CrossRefGoogle ScholarPubMed
Grondin, R. et al., 1999. D1 receptor blockade improves L-dopa-induced dyskinesia but worsens parkinsonism in MPTP monkeys. Neurology, 52(4), pp. 771–776.CrossRefGoogle ScholarPubMed
Hooker, E.A. and Danzl, D.F., 1988. Acute dystonic reaction due to diazepam. The Journal of Emergency Medicine, 6(6), pp. 491–493.CrossRefGoogle ScholarPubMed
Howrie, D.L., Rowley, A.H. and Krenzelok, E.P., 1986. Benztropine-induced acute dystonic reaction. Annals of Emergency Medicine, 15(5), pp. 594–596.CrossRefGoogle ScholarPubMed
Incecik, F. et al., 2011. Albendazole-induced dystonic reaction: a case report. The Turkish Journal of Pediatrics, 53(6), pp. 709–710.Google ScholarPubMed
Jankovic, J., 2013. Medical treatment of dystonia. Movement Disorders, 28(7), pp. 1001–1012.CrossRefGoogle ScholarPubMed
Kapur, S. et al., 2000. Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia. The American Journal of Psychiatry, 157(4), pp. 514–520.CrossRefGoogle ScholarPubMed
Kapur, V., Barber, K.R. and Peddireddy, R., 1999. Ranitidine-induced acute dystonia. The American Journal of Emergency Medicine, 17(3), pp. 258–260.CrossRefGoogle ScholarPubMed
Kastrup, O., Gastpar, M. and Schwarz, M., 1994. Acute dystonia due to clozapine. Journal of Neurology, Neurosurgery and Psychiatry, 57(1), pp. 119–119.CrossRefGoogle ScholarPubMed
Kerrick, J.M. et al., 1995. Involuntary movement disorders associated with felbamate. Neurology, 45(1), pp. 185–187.CrossRefGoogle ScholarPubMed
Kolbe, H. et al., 1981. Neuroleptic‐induced acute dystonic reactions may be due to enhanced dopamine release on to supersensitive postsynaptic receptors. Neurology, 31(4), pp. 434–434.CrossRefGoogle Scholar
Leitner, M.L. et al., 1994. Regional variation in the ratio of sigma 1 to sigma 2 binding in rat brain. European Journal of Pharmacology, 259(1), pp. 65–69.CrossRefGoogle ScholarPubMed
Linazasoro, G., Martí Massó, J.F. and Olasagasti, B., 1991. Acute dystonia induced by sulpiride. Clinical Neuropharmacology, 14(5), pp. 463–2.CrossRefGoogle ScholarPubMed
López-Alemany, M., Ferrer-Tuset, C. and Bernácer-Alpera, B., 1997. Akathisia and acute dystonia induced by sumatriptan. Journal of Neurology, 244(2), pp. 131–132.CrossRefGoogle ScholarPubMed
Lu, C.S. and Chu, N.S., 1988. Acute dystonic reaction with asterixis and myoclonus following metoclopramide therapy. Journal of Neurology, Neurosurgery and Psychiatry, 51(7), pp. 1002–1003.CrossRefGoogle ScholarPubMed
Madej, T.H., 1985. Domperidone – an acute dystonic reaction. Anaesthesia.CrossRefGoogle Scholar
Marsden, C.D. and Jenner, P., 1980. The pathophysiology of extrapyramidal side-effects of neuroleptic drugs. Psychological Medicine, 10(1), pp. 55–72.CrossRefGoogle ScholarPubMed
Marsden, C.D., Tarsy, D. and Baldessarini, R.J., 1975. Spontaneous and drug induced movement disorders in psychotic patients. In Psychiatric Aspects of Neurologic Disease. New York: Grune & Stratton, pp. 219–266.Google Scholar
Matsumoto, R.R. and Pouw, B., 2000. Correlation between neuroleptic binding to sigma(1) and sigma(2) receptors and acute dystonic reactions. European Journal of Pharmacology, 401(2), pp. 155–160.CrossRefGoogle Scholar
Mellacheruvu, S., Norton, J.W. and Schweinfurth, J., 2007. Atypical antipsychotic drug-induced acute laryngeal dystonia: 2 case reports. Journal of Clinical Psychopharmacotherapy, 27(2), pp. 206–207.CrossRefGoogle ScholarPubMed
Mendhekar, D. and War, L., 2014. Olanzapine induced acute Meige’s syndrome. Journal of Neuropsychiatry Clinical Neuroscience, pp. 1–1.Google Scholar
Méndez Guerrero, A. et al., 2013. Acute Pisa syndrome after administration of a single dose of mirtazapine. Clinical Neuropharmacology, 36(4), pp. 133–134.CrossRefGoogle ScholarPubMed
Micheli, F. et al., 1987. Flunarizine‐ and cinnarizine‐induced extrapyramidal reactions. Neurology, 37(5), pp. 881–881.CrossRefGoogle ScholarPubMed
Dominguez-Moran, et al., 2001. Acute paroxysmal dystonia induced by fluoxetine. Movement Disorders, 16(4), pp. 767–769.CrossRefGoogle ScholarPubMed
Newton-John, H., 1988. Acute upper airway obstruction due to supraglottic dystonia induced by a neuroleptic. BMJ (Clinical Research Ed.), 297(6654), pp. 964–965.CrossRefGoogle ScholarPubMed
Panagiotis, I. et al., 2012. Acute Pisa syndrome after administration of a single dose of donepezil. The Journal of Neuropsychiatry and Clinical Neurosciences, 24 (3), p. E26.CrossRefGoogle Scholar
Patel, A. et al., 2011. Ondansetron-induced dystonia, hypoglycemia, and seizures in a child. Annals of Pharmacotherapy, 45 (1), p. e7.CrossRefGoogle ScholarPubMed
Pong, M., Horn, K.M. and Gibson, A.R., 2008. Pathways for control of face and neck musculature by the basal ganglia and cerebellum. Brain Research Reviews, 58(2), pp. 249–264.CrossRefGoogle ScholarPubMed
Redgrave, P., Prescott, T.J. and Gurney, K., 1999. The basal ganglia: a vertebrate solution to the selection problem? Neuroscience, 89(4), pp. 1009–1023.CrossRefGoogle Scholar
Reecer, M.V., Clinchot, D.M. and Tipton, D.B., 1993. Drug-induced dystonia in a patient with C4 quadriplegia. Case report. American Journal of Physical Medicine and Rehabilitation / Association of Academic Physiatrists, 72(2), pp. 97–98.Google Scholar
Robert, F. et al., 2010. Acute camptocormia induced by olanzapine: a case report. Journal of Medical Case Reports, 4(1), p. 192.CrossRefGoogle ScholarPubMed
Romanelli, P. et al., 2005. Somatotopy in the basal ganglia: experimental and clinical evidence for segregated sensorimotor channels. Brain Research Reviews, 48(1), pp. 112–128.CrossRefGoogle ScholarPubMed
Saddichha, S. et al., 2013. Aripiprazole associated with acute dystonia, akathisia, and parkinsonism in a single patient. The Journal of Clinical Pharmacology, 52(9), pp. 1448–1449.CrossRefGoogle Scholar
Schneider, S.A. et al., 2009. Recurrent acute dystonic reaction and oculogyric crisis despite withdrawal of dopamine receptor blocking drugs. Movement Disorders, 24(8), pp. 1226–1229.CrossRefGoogle ScholarPubMed
Schumock, G.T. and Martinez, E., 1991. Acute oculogyric crisis after administration of prochlorperazine. Southern Medical Journal, 84(3), pp. 407–408.CrossRefGoogle ScholarPubMed
Silfeler, I. et al., 2012. Development of acute dystonia in three brothers due to metoclopramide. Journal of Research in Medical Sciences: The Official Journal of Isfahan University of Medical Sciences, 17(3), pp. 308–309.Google ScholarPubMed
Simpson, G.M. and Lindenmayer, J.P., 1997. Extrapyramidal symptoms in patients treated with risperidone. Journal of Clinical Psychopharmacotherapy, 17(3), pp. 194–201.CrossRefGoogle ScholarPubMed
Singh, M.K., DelBello, M.P. and Adler, C.M., 2007. Acute dystonia associated with aripiprazole in a child. Journal of the American Academy of Child and Adolescent Psychiatry, 46(3), pp. 306–307.CrossRefGoogle ScholarPubMed
Song, X., Hu, Z. and Zhang, H., 2005. Acute dystonia induced by lamivudine. Clinical Neuropharmacology, 28(4), pp. 193–194.CrossRefGoogle ScholarPubMed
Spina, E., Sturiale, V., Valvo, S., Ancione, M., Di Rosa, A.E., Meduri, M. and Caputi, A.P., 1993. Prevalence of acute dystonic reactions associated with neuroleptic treatment with and without anticholinergic prophylaxis. International Clinical Psychopharmacology, 8(1), pp. 21–24.CrossRefGoogle ScholarPubMed
Swett, C., 1975. Drug-induced dystonia. The American Journal of Psychiatry, 132(5), pp. 532–534.Google ScholarPubMed
Uca, A.U., Kozak, H.H. and Uguz, F., 2014. Varenicline-induced acute dystonic reaction: a case report. General Hospital Psychiatry, 36(3), pp. 361.e1–2.CrossRefGoogle ScholarPubMed
van der Meer, J.N. et al., 2012. White matter abnormalities in gene-positive myoclonus-dystonia. Movement Disorders, 27(13), pp. 1666–1672.CrossRefGoogle ScholarPubMed
van Waarde, A. et al., 2011. The cholinergic system, sigma-1 receptors and cognition. Behavioural Brain Research, 221(2), pp. 543–554.CrossRefGoogle ScholarPubMed
Varkula, M. and Dale, R., 2008. Acute dystonic reaction after initiating aripiprazole monotherapy in a 20-year-old man. Journal of Clinical Psychopharmacotherapy, 28(2), pp. 1–21.Google ScholarPubMed
Vena, J., Dufel, S. and Paige, T., 2006. Acute olanzapine-induced akathisia and dystonia in a patient discontinued from fluoxetine. The Journal of Emergency Medicine, 30(3), pp. 311–317.CrossRefGoogle Scholar
Venkateswaran, P.S. and Otto, A.G., 1972. Acute dystonia due to metoclopramide. British Medical Journal, 4(5833), pp. 178–179.CrossRefGoogle ScholarPubMed
Viana, B. de M. et al., 2009. Ziprasidone-related oculogyric crisis in an adult. Clinical Neurology and Neurosurgery, 111(10), pp. 883–885.CrossRefGoogle ScholarPubMed
Wang, G.J. et al., 1996. Age associated decrements in dopamine D2 receptors in thalamus and in temporal insula of human subjects. Life Sciences, 59(1), pp. PL31–5.CrossRefGoogle ScholarPubMed
Waugh, J.L., 2013. Acute dyskinetic reaction in a healthy toddler following methylphenidate ingestion. Pediatric Neurology, 49(1), pp. 58–60.CrossRefGoogle Scholar
Yumru, M. et al., 2006. Acute dystonia after initial doses of ziprasidone: A case report. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 30(4), pp. 745–747.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×